University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

E

Status Drug name NICE TAs Comments
Status: Green Eucerin® intensive lotion (10% urea)
Status: Green Eurax hydrocortisone® cream

Mild steroid potency. Post-scabies once infection cleared but itch still present

Status: Red Everolimus (Afinitor®)

Negative outcome - CDF funded for renal, NET, breast. For hospital use only.

Status: Red Everolimus (Votubia®)

As recommended by NHSE

Refractory seizures associated with tuberous sclerosis

Status: Red Evicel

Hospital use only

Status: Red Evolocumab

& Homozygous familial hypercholesterola EMIA in line with NHS England SSC 1649

To be used in line with NICE TA

Status: Amber Evra (patches)

Umbrella service only - patients with compliance problems and metabolic problems

Status: Amber Exemestane tablets
Status: Green Exenatide prolonged release injection (Bydureon®)
Status: Green Ezetimibe tablets

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top